Earnings Feed
Start Free
Athenex, Inc.·4

Jul 21, 5:28 PM ET

Lang Daniel 4

4 · Athenex, Inc. · Filed Jul 21, 2022

Insider Transaction Report

Form 4
Period: 2022-07-20
Athenex, Inc.ATNX
Lang Daniel
Pres Cell Therapy, VP Corp Dev
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-07-20+200,000→ 200,000 total
    Exercise: $0.67Exp: 2032-07-20→ Common Stock (200,000 underlying)
Holdings

  • Stock Option (Right to Buy)

    Exercise: $10.25Exp: 2030-08-27→ Common Stock (40,000 underlying)
    40,000

  • Stock Option (Right to Buy)

    Exercise: $2.77Exp: 2031-09-16→ Common Stock (50,000 underlying)
    50,000

  • Restricted Stock Units

    → Common Stock (50,000 underlying)
    50,000

  • Common Stock

    73,413
Footnotes (6)
  • [F1]Includes 30,000 shares subject to a restricted stock award vesting in four equal annual installments beginning on August 26, 2020.
  • [F2]This option vests in four equal annual installments beginning on August 27, 2021.
  • [F3]This option vests in four equal annual installments beginning on September 16, 2022.
  • [F4]Each restricted stock unit represents a contingent right to receive one share of stock.
  • [F5]The restricted stock units vest in four equal annual installments beginning on September 16, 2022.
  • [F6]This option vests in four equal annual installments beginning on July 20, 2023.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION